SGL-TX-MR-研究协议SGLT2抑制剂对代移植氧气张力的急性影响,这是一个随机,双盲,安慰剂控制的交叉试验
Lotte Borg Lange1, Claus Bistrup2
1Department of Nephrology, Odense University Hospital, Kløvervænget 6, Odense C, DK-5000, Denmark. Lotte.Borg.Lange@rsyd.dk.
Trials
|December 30, 2025
概括
这项研究将调查-葡萄糖共同输送体2型抑制剂 (SGLT2i) 是否能改善非糖尿病移植受体的代移植氧化. 这些发现可能会揭示移植氧的新疗法策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植医学 移植医学
- 药理学 药理学是指药理学的学科.
背景情况:
- SGLT2 抑制剂对非糖尿病患者移植的急性影响仍未得到研究.
- 非糖尿病移植接受者 (KTR) 可能从了解SGLT2抑制机制中受益.
研究的目的:
- 评估SGLT2抑制剂对非糖尿病KTR患者代移植氧气张力的急性作用.
- 在移植的背景下探索SGLT2抑制剂的潜在保护机制.
主要方法:
- 一个随机,双盲,安慰剂控制的交叉试验 (SGL-TX-MR) 涉及八名非糖尿病KTR.
- 一次剂量的Jardiance (SGLT2i) 或安慰剂,两周的洗期.
- 使用基于MRI的T2*放松率评估移植皮质和髓氧张力.
主要成果:
- 这个部分将报告脏氧气张力,输液,血流,葡萄糖,血压和心率干预后的变化.
- 分析SGLT2i给药是否在3-6小时内急性增强皮层氧化.
结论:
- 这项研究旨在确定SGLT2抑制剂是否能改善非糖尿病移植患者的氧化.
- 结果可以阐明SGLT2i的脏保护机制,并为脏全移植缺氧的治疗提供信息.
相关概念视频
02:07Blind Procedures
10.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.8K
01:27Glucose Transporters
15.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.3K